Josh Enomoto

Josh Enomoto

Brokering multi-million-dollar deals with some of the world’s biggest companies and providing in-depth marketing analyses, Josh Enomoto takes his firsthand knowledge of the corporate boardroom and delivers them across several media outlets. In addition to his work at InvestorPlace, Josh contributes content for Benzinga, TipRanks, EmergingGrowth and Blockster. He is also a guest expert at CGTN America.

While leaving no stone unturned regarding sector coverage, Josh has written extensively about cryptocurrencies. You can follow him on Blockster, a crypto-centric social media platform and on LinkedIn.

Recent Articles

Why Roblox Is Not a Buy Regardless of a Discount

One of the common arguments for RBLX stock is that it’s a buy on the dip. But the financials suggest you should avoid it regardless.

7 Stocks to Start your Robinhood Portfolio With Just $2,000

Despite their reputation, Robinhood stocks to buy are surprisingly viable. Here are seven to acquire if you just have $2,000 to start.

Clover Health Stock Simply Has Too Much Toxic Baggage Right Now

CLOV stock has absorbed a steep discount and when you consider the broader context, it probably deserves it.

Marathon Digital Holdings Has a Familiar Look, Unfortunately

MARA stock may seem appealing due to its discount but its contrasting price action relative to cryptocurrencies is worrying.

Why You Don’t Want Cardano to Hit $10

While some analysts are forecasting some wild upside targets for Cardano, investors should think about the implications.